About Pan American Center for Oncology Trials (PanOncology Trials)
"PanOncology Trials es un centro especializado en cáncer, ofreciendo tratamiento avanzados para pacientes luchando contra la enfermedad. Las terapias, visitas médicas, pruebas de laboratorios y radiografías relacionadas con el estudio clinico son libres de costo. Los patrocinadores de los estudios, primordiamente farmacéuticas y centros de investigación, cubren los costos asociados a las terapias. Nuestro equipo de investigadores y personal clínico tienen sobre 75 años de experiencia combinada realizando estudios clínicos de investigación."
Clinical Trials at Pan American Center for Oncology Trials (PanOncology Trials)
During the past decade, Pan American Center for Oncology Trials (PanOncology Trials) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Pan American Center for Oncology Trials (PanOncology Trials)
According to Clinical.Site data, the most researched conditions in "Pan American Center for Oncology Trials (PanOncology Trials)" are
"Cancer" (2 trials), "Cancer of Pancreas" (2 trials), "Colorectal Cancer" (2 trials), "Non Small Cell Lung Cancer" (2 trials) and "Solid Tumor" (2 trials). Many other conditions were trialed in "Pan American Center for Oncology Trials (PanOncology Trials)" in a lesser frequency.
Clinical Trials Intervention Types at Pan American Center for Oncology Trials (PanOncology Trials)
Most popular intervention types in "Pan American Center for Oncology Trials (PanOncology Trials)" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Alectinib" (1 trials), "Atezolizumab" (1 trials), "Belvarafenib" (1 trials), "Entrectinib" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Pan American Center for Oncology Trials (PanOncology Trials)
The vast majority of trials in "Pan American Center for Oncology Trials (PanOncology Trials)" are
4 trials for "All" genders.
Clinical Trials Status at Pan American Center for Oncology Trials (PanOncology Trials)
Currently, there are NaN active trials in "Pan American Center for Oncology Trials (PanOncology Trials)".
undefined are not yet recruiting,
4 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Pan American Center for Oncology Trials (PanOncology Trials),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Pan American Center for Oncology Trials (PanOncology Trials), 2 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".